tradingkey.logo

Autonomix Medical Inc

AMIX
查看詳細走勢圖
0.398USD
+0.045+12.67%
收盤 02/06, 16:00美東報價延遲15分鐘
2.47M總市值
虧損本益比TTM

Autonomix Medical Inc

0.398
+0.045+12.67%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+12.67%

5天

+0.10%

1月

-19.42%

6月

-67.87%

今年開始到現在

-27.56%

1年

-85.24%

查看詳細走勢圖

TradingKey 股票評分

由於缺少必要的數據,暫時無法對該公司進行評分

Autonomix Medical Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Autonomix Medical Inc簡介

Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.
公司代碼AMIX
公司Autonomix Medical Inc
CEOHauser (Bradley)
網址https://autonomix.com/
KeyAI